NME2 and breast carcinoma: In the experiments detailed in this study, by assessing the levels of the transcription factor c-MYC and its target gene product SOD2, we observed a significant decrease in the content of the c-MYC transcription factor and a corresponding downregulation of its target gene SOD2 expression following treatment with N8 in breast cancer cells.